Please login to the form below

Not currently logged in
Email:
Password:

Fishawack appoints Jenifer Kirkland as CFO

She succeeds Dominic Miller who becomes COO at the med comms agency

Jenifer Kirkland Fishawack has appointed Jenifer Kirkland as its chief financial officer in a role that will see her take responsibility for the independent medical communications group's internal and external financial reporting.

Kirkland previous positions at Ernst and Young, BT, Pearson and was most recently chief financial officer for life sciences consultancy Kinapse.

She said: “Having understood the Fishawack team’s strategy and plan to grow the group, I am looking forward to being part of such a thriving company, contributing to the success and meeting the teams across the offices who are making this happen.”

Kirkland succeeds Dominic Miller, who will assume the responsibilities of chief operations officer, working closely with the group’s chief executive officer Oliver Dennis on further agency acquisitions.

Dennis said: “Jenifer’s experience and leadership will be invaluable to scaling up our finance function as we set out on our next phase of growth.”

4th July 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics